Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

08/29/17 RC -- Ure-Na for hyponatremia

We may start to see orders for Ure-Na, an oral powder classified as a medical food and used for treatment of euvolemic or hypervolemic hyponatremia, including SIADH. The dose is 15-60 grams/day, and adverse effects include hypernatremia and stomach upset. It has shown to increase sodium levels up to a range comparable to tolvaptan, although study information is limited. The cost is about $3.80 for a 15 gram dose, compared to tolvaptan at almost $400/dose. There is a pharmacist consult for sodium monitoring similar to tolvaptan, for new orders and dosage changes, a baseline sodium should be obtained, followed by an 8 hour post-dose sodium level, then additional monitoring is per pharmacist judgement, with a daily sodium level obtained. 






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.